Clinical Trials Insight: 700046359

Trial Profile

Clinical Trials Insight: 700046359

Phase of Trial: Phase I

Latest Information Update: 25 Aug 2010

At a glance

  • Drugs ADX 71149 (Primary)
  • Indications Anxiety disorders; CNS disorders; Depressive disorders; Schizophrenia
  • Focus Adverse reactions
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 25 Aug 2010 Status changed from recruiting to completed according to information in an Addex Pharmaceuticals media release.
    • 29 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top